These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9740911)

  • 41. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 42. ASHP guidelines on pharmacists' relationships with industry.
    Am J Hosp Pharm; 1992 Jan; 49(1):154. PubMed ID: 1510758
    [No Abstract]   [Full Text] [Related]  

  • 43. The pharmacist's responsibility in the choice of drug products.
    Am J Hosp Pharm; 1970 May; 27(5):365. PubMed ID: 5422275
    [No Abstract]   [Full Text] [Related]  

  • 44. ASHP statement on third-party compensation for clinical services by pharmacists.
    Am J Hosp Pharm; 1985 Jul; 42(7):1580-1. PubMed ID: 4025361
    [No Abstract]   [Full Text] [Related]  

  • 45. Dealing with substance abuse in the workplace.
    Malatestinic WN; Jorgenson JA
    Hosp Pharm; 1991 Feb; 26(2):102-5. PubMed ID: 10170679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ASHP statement on the role of the pharmacist in patient-focused care. American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 1995 Aug; 52(16):1808-10. PubMed ID: 8528840
    [No Abstract]   [Full Text] [Related]  

  • 47. ASHP statement on clinical functions in institutional pharmacy practice.
    Am J Hosp Pharm; 1978 Jul; 35(7):813. PubMed ID: 665700
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmaceutical education in perspective.
    Brodie DC
    Am J Hosp Pharm; 1982 Apr; 39(4):587-94. PubMed ID: 7081234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacists against drug abuse.
    Cruikshank D
    Med Law; 1989; 8(6):641-4. PubMed ID: 2517998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical research: ASHP guidelines and future directions for pharmacists.
    Phillips MS
    Am J Health Syst Pharm; 1999 Feb; 56(4):344-6. PubMed ID: 10690218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ASHP policy-development process: opportunities for improvement. ASHP Ad Hoc Committee on Policy Development.
    Am J Health Syst Pharm; 1998 May; 55(10):1044-9. PubMed ID: 9606458
    [No Abstract]   [Full Text] [Related]  

  • 52. ASHP guidelines for pharmacists on the activities of vendors' representatives in organized health care systems. American Society of Hospital Pharmacists.
    Meyer GE; Keith TD; Gutfeld MB; Johnson D
    Am J Hosp Pharm; 1994 Feb; 51(4):520-1. PubMed ID: 8017422
    [No Abstract]   [Full Text] [Related]  

  • 53. ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. This official ASHP practice standard was developed through the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 16, 1996.
    Am J Health Syst Pharm; 1997 Feb; 54(3):299-313. PubMed ID: 9028424
    [No Abstract]   [Full Text] [Related]  

  • 54. ASHP guidelines on pharmacist-conducted patient counseling.
    Am J Hosp Pharm; 1993 Mar; 50(3):505-6. PubMed ID: 8442471
    [No Abstract]   [Full Text] [Related]  

  • 55. The hospital pharmacist's role in health education.
    Cue EK
    Am J Hosp Pharm; 1971 Sep; 28(9):697-700. PubMed ID: 5132063
    [No Abstract]   [Full Text] [Related]  

  • 56. The politics of prevention: changing definitions of substance use/abuse.
    Goldstein MB; Engwall DB
    J Health Soc Policy; 1992; 3(3):69-83. PubMed ID: 10170971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Position and task of health education within the role of the pharmacist's activity].
    Solich J; Hartlová S; Salava M
    Cesk Farm; 1975 Jun; 24(4-5):149-50. PubMed ID: 1182814
    [No Abstract]   [Full Text] [Related]  

  • 58. ASHP Practitioner Recognition Program--2010 Fellows of the American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 2010 Jul; 67(13):e16-33. PubMed ID: 20554584
    [No Abstract]   [Full Text] [Related]  

  • 59. ASHP Practitioner Recognition Program--2010 Fellows of the American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 2010 Jul; 67(13):1118. PubMed ID: 20554600
    [No Abstract]   [Full Text] [Related]  

  • 60. The pharmacist's role in a community drug addiction treatment program.
    Burleson K
    Hosp Pharm; 1975 Aug; 10(8):327-8, 332. PubMed ID: 10316679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.